Close X

The myESMO community is an international network of over 6'000 oncology professionals, sharing best practices and the latest know-how in cancer treatment and care

Join myESMO
to access our members only benefits

Click to discover ESMO

Already have an
ESMO Account?

 
Username: Password:
Remember me!
Forgot your Password?
Close X

You are trying to access a members only resource.
Please log-in.

 
Username: Password:
Remember me!

Forgot your Password?

join us

Not a Member yet?

Get involved, stay connected:
Join myESMO community today

Position statements and recommendations

ESMO Statement on the European Council Recommendation on Rare Diseases
This ESMO statement compliments the ESMO-supported "European Action Against Rare Cancers". Please join us and sign the Call to Action Against Rare Cancers.

ESMO position statements on the role of medical oncologists in the fight against cancer in Europe

Improving Rare Cancer Care in Europe
ESMO Consensus Recommendations on New Drugs in Rare Cancers
For more information on European Action against Rare Cancers, please click here

ESMO statement on the European Parliament Resolution on combating cancer in an enlarged European Union

ESMO comments on the 'Public consultation regarding a European Action in the Field of Rare Diseases' (Rare Diseases: Europe's Challenges)
The document includes answers to the 14 specific questions identified in the text and mainly focuses on rare tumors where necessary.

ESMO comments on the legal framework for information to patients with reference to a public consultation organized by the European Commission in February–April 2008

ESMO comments on the 'Consultation regarding draft report on current practice with regard to provision of information to patients on medicinal products in accordance with art. 88a of Directive 2001/83/EC as amended by Directive 2004/27/EC on the Community.
The document includes global assessment of the draft report, general comments and suggestions.

ESMO position statement on the 'Consultation regarding Community Action on Health Services' in 2006
The statement provides overall considerations and specific responses by ESMO to nine questions regarding cross-border healthcare in EU Member States.